Published in J Clin Invest on August 01, 1992
Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest (1993) 1.94
Cytokines link Toll-like receptor 4 signaling to cardiac dysfunction after global myocardial ischemia. Ann Thorac Surg (2008) 1.91
TNF-alpha inhibition attenuates adverse myocardial remodeling in a rat model of volume overload. Am J Physiol Heart Circ Physiol (2009) 1.17
Temporal expression of pro-inflammatory cytokines and inducible nitric oxide synthase in experimental acute Chagasic cardiomyopathy. Am J Pathol (1998) 1.12
C-reactive protein, diastolic dysfunction, and risk of heart failure in patients with coronary disease: Heart and Soul Study. Eur J Heart Fail (2007) 1.10
Increased interleukin-6 but not tumour necrosis factor-alpha predicts mortality in the population of elderly heart failure patients. Exp Clin Cardiol (2008) 1.02
Recent insights into the role of tumor necrosis factor in the failing heart. Heart Fail Rev (2001) 0.93
Psychobiology of depression/distress in congestive heart failure. Heart Fail Rev (2008) 0.92
Assessment of inflammation in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Eur J Nucl Med Mol Imaging (2010) 0.90
Biology of TNFalpha and IL-10, and their imbalance in heart failure. Heart Fail Rev (2008) 0.87
The role of nitric oxide in the failing heart. Heart Fail Rev (2001) 0.85
Mitral valve reconstruction in the patient with heart failure. Heart Fail Rev (2001) 0.84
Effects of tumour necrosis factor-alpha on left ventricular function in the rat isolated perfused heart: possible mechanisms for a decline in cardiac function. Br J Pharmacol (1999) 0.84
Beneficial effects of nitric oxide on cardiac diastolic function: 'the flip side of the coin'. Heart Fail Rev (2000) 0.80
Cardiovascular dysfunction in burns: review of the literature. Ann Burns Fire Disasters (2012) 0.80
Depletion of phagocytes in the reticuloendothelial system causes increased inflammation and mortality in rabbits with Pseudomonas aeruginosa pneumonia. Am J Physiol Lung Cell Mol Physiol (2008) 0.80
Tumor necrosis factor-α confers cardioprotection through ectopic expression of keratins K8 and K18. Nat Med (2015) 0.80
Immune modulation of cardiac cell function. Trans Am Clin Climatol Assoc (1998) 0.79
Interaction between interleukin-1 beta and angiotensin II receptor 1 in hypothalamic paraventricular nucleus contributes to progression of heart failure. J Interferon Cytokine Res (2014) 0.77
Exercise training, inflammation and heart failure: working out to cool down. J Physiol (2010) 0.77
Mechanism of cardioprotective action of TNF-alpha in the isolated rat heart. Exp Clin Cardiol (2002) 0.76
Noninvasive monitoring of hemodynamic changes in acute pancreatitis in rabbits. Dig Dis Sci (1997) 0.76
Effects of carvedilol on plasma levels of pro-inflammatory cytokines in patients with ischemic and nonischemic dilated cardiomyopathy. Tex Heart Inst J (2007) 0.76
Interactions between cytokines and neurohormonal systems in the failing heart. Heart Fail Rev (2001) 0.75
Activation of cytokines as a mechanism of disease progression in heart failure. Ann Rheum Dis (2000) 0.75
Association of TNFSF8 polymorphisms with peripheral neutrophil count. Mayo Clin Proc (2011) 0.75
Case report: severe reversible cardiomyopathy associated with systemic inflammatory response syndrome in the setting of diabetic hyperosmolar hyperglycemic non-ketotic syndrome. BMC Cardiovasc Disord (2015) 0.75
Pathological observation of acute myocardial infarction in Chinese miniswine. Int J Clin Exp Med (2015) 0.75
Resolution of Cosmetic Buttock Injection-induced Inflammatory Reaction and Heart Failure after Excision of Filler Material. Plast Reconstr Surg Glob Open (2016) 0.75
Elevated circulating levels of tumor necrosis factor in patients with mitral valve disease and ventricular septum defect. Heart Vessels (1996) 0.75
Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science (1985) 19.41
Shock and tissue injury induced by recombinant human cachectin. Science (1986) 16.24
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature (1988) 13.42
Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med (1988) 7.96
Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet (1987) 7.24
Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J Clin Invest (1988) 5.22
An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumor necrosis factor-alpha increases neutrophil adherence by a CDw18-dependent mechanism. J Immunol (1986) 5.14
Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. J Clin Invest (1988) 4.76
Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surg Gynecol Obstet (1987) 4.18
Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation (1983) 4.01
Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med (1984) 3.81
Cytokine appearance in human endotoxemia and primate bacteremia. Surg Gynecol Obstet (1988) 3.30
Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice. Proc Natl Acad Sci U S A (1988) 3.04
Tumor necrosis factor stimulates interleukin-1 and prostaglandin E2 production in resting macrophages. Biochem Biophys Res Commun (1986) 2.96
Patterns of septic shock in man--a detailed study of 56 patients. Ann Surg (1967) 2.79
Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med (1989) 2.69
Linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work. Circulation (1985) 2.65
Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion. J Clin Invest (1988) 2.46
Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol (1983) 2.37
Tumor necrosis factor provokes superoxide anion generation from neutrophils. Biochem Biophys Res Commun (1986) 2.27
Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor. J Clin Invest (1988) 2.23
Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage. J Clin Invest (1989) 2.13
Role of leukocytes in acute myocardial infarction in anesthetized dogs: relationship to myocardial salvage by anti-inflammatory drugs. J Pharmacol Exp Ther (1984) 2.12
The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors. Proc Natl Acad Sci U S A (1987) 2.10
Acute in vivo effects of human recombinant tumor necrosis factor. Lab Invest (1987) 2.06
Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. Am J Physiol (1986) 1.99
The three-dimensional dynamic geometry of the left ventricle in the conscious dog. Circ Res (1976) 1.93
Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock. J Clin Invest (1989) 1.87
Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness. Proc Natl Acad Sci U S A (1989) 1.83
Cellular mechanisms of myocardial infarct expansion. Circulation (1988) 1.77
Phase I study of recombinant tumor necrosis factor in cancer patients. Cancer Res (1987) 1.74
Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase I and pharmacologic study. J Natl Cancer Inst (1988) 1.73
Neutrophil adherence to isolated adult canine myocytes. Evidence for a CD18-dependent mechanism. J Clin Invest (1990) 1.52
Induction of tumor necrosis factor, IFN-gamma, and acute lethality in mice by toxic and non-toxic forms of lipid A. J Immunol (1988) 1.38
Left ventricular performance in septic shock: reversible segmental and global abnormalities. Am Heart J (1985) 1.38
Factors which affect the diastolic pressure-volume curve. Circ Res (1978) 1.35
Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock. J Clin Invest (1986) 1.34
Detection of tumour necrosis factor-like cytotoxicity in serum from patients with septicaemia but not from untreated cancer patients. Scand J Immunol (1986) 1.29
The effects of tumor necrosis factor and their selective inhibition by ibuprofen. Ann Surg (1989) 1.29
Mechanism of cytokine inhibition of beta-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes. Impairment of signal transduction. Circ Res (1990) 1.26
Profound structural alterations of the extracellular collagen matrix in postischemic dysfunctional ("stunned") but viable myocardium. J Am Coll Cardiol (1987) 1.20
Differential expression of interleukin-1 and tumor necrosis factor in murine septic shock models. Circ Shock (1989) 1.19
Left ventricular myocardial edema. Lymph flow, interstitial fibrosis, and cardiac function. Circ Res (1991) 1.16
Superoxide dismutase plus catalase improve contractile function in the canine model of the "stunned myocardium". Circ Res (1986) 1.15
Evaluation of nonradioactive, colored microspheres for measurement of regional myocardial blood flow in dogs. Circulation (1988) 1.12
Human recombinant tumor necrosis factor alpha infusion mimics endotoxemia in awake sheep. J Appl Physiol (1985) (1989) 1.06
Viscoelastic properties of the diastolic left ventricle in the conscious dog. Circ Res (1977) 1.04
Granulocytes cause reperfusion ventricular dysfunction after 15-minute ischemia in the dog. Circ Res (1987) 1.02
Cardiovascular performance with E. coli challenges in a canine model of human sepsis. Am J Physiol (1988) 1.02
Recombinant human tumor necrosis factor produces hemodynamic changes characteristic of sepsis and endotoxemia. Arch Surg (1989) 1.00
Maximal negative dP/dt as an indicator of end of systole. Am J Physiol (1981) 0.94
Tumor necrosis factor-enhanced leukotriene B4 generation and chemotaxis in human neutrophils. Arch Surg (1988) 0.93
Tumor necrosis factor alpha stimulates leukotriene production in vivo. Eur J Immunol (1988) 0.93
The effects of acutely increased ventricular cavity pressure on intrinsic myocardial connective tissue. J Am Coll Cardiol (1988) 0.87
Myocardial salvage induced by REV-5901: an inhibitor and antagonist of the leukotrienes. J Cardiovasc Pharmacol (1987) 0.86
Thromboxane synthetase inhibitors reduce infarct size by a platelet-dependent, aspirin-sensitive mechanism. Circ Res (1988) 0.86
Early in reperfusion, leukocytes alter perfused coronary capillarity and vascular resistance. Am J Physiol (1989) 0.86
Coronary constriction by leukotriene C4, D4, and E4 in the intact pig heart. Am J Cardiol (1983) 0.85
Continuous infusion of tumor necrosis factor: mechanisms of toxicity in the rat. J Surg Res (1988) 0.85
Cardiovascular and pulmonary effects of human recombinant tumor necrosis factor in the conscious rat. Circ Shock (1989) 0.85
Plasma levels of 6-keto PGF1 alpha but not TxB2 increase in rats with peritonitis due to cecal ligation. Circ Shock (1985) 0.84
Quantification of regional myocardial dysfunction after acute ischemic injury. Am J Physiol (1988) 0.84
Sepsis-induced diastolic dysfunction in chronic canine peritonitis. Am J Physiol (1990) 0.80
Relation between reversal of diastolic creep and recovery of systolic function after ischemic myocardial injury in conscious dogs. Circ Res (1987) 0.78
Assessment of the intrinsic contractile status of the heart during sepsis by myocardial pressure-dimension analysis. Ann Surg (1988) 0.76
Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. N Engl J Med (1991) 9.99
Ice nucleation temperature of individual leaves in relation to population sizes of ice nucleation active bacteria and frost injury. Plant Physiol (1985) 2.32
Are low tidal volumes safe? Chest (1990) 2.26
Effect of antenatal betamethasone administration on placental vascular resistance. Lancet (1999) 2.17
Ringer's ethyl pyruvate solution ameliorates ischemia/reperfusion-induced intestinal mucosal injury in rats. Crit Care Med (2001) 2.12
Tissue capnometry as a monitoring strategy for critically ill patients: just about ready for prime time. Chest (1998) 2.04
The direct cost of low birth weight. Future Child (1995) 1.99
Gastric tonometry and venous oximetry in cardiac surgery patients. Crit Care Med (1991) 1.94
Cytokine-induced intestinal epithelial hyperpermeability: role of nitric oxide. Crit Care Med (1999) 1.81
Economic implications of neonatal intensive care unit collaborative quality improvement. Pediatrics (2001) 1.75
Acidic conditions exacerbate interferon-gamma-induced intestinal epithelial hyperpermeability: role of peroxynitrous acid. Crit Care Med (1999) 1.69
Inhibition of inducible nitric oxide synthase ameliorates endotoxin-induced gut mucosal barrier dysfunction in rats. Gastroenterology (1997) 1.67
Excess cost of emergency department visits for nonurgent care. Health Aff (Millwood) (1994) 1.66
Hormonal responses to graded surgical stress. Arch Intern Med (1987) 1.59
Feasibility of non-invasive measurement of tissue pH using near-infrared reflectance spectroscopy. J Clin Monit (1996) 1.46
Use of ultrahigh frequency ventilation in patients with ARDS. A preliminary report. Chest (1993) 1.45
Nitric oxide donors increase cytosolic ionized calcium in cultured human intestinal epithelial cells. Shock (1996) 1.40
CT grading of splenic trauma in adults: how the same statistics can be interpreted differently. Radiology (1991) 1.39
Secondary infection of post-traumatic pulmonary cavitary lesions in adolescents and young adults: role of computed tomography and operative debridement and drainage. J Trauma (1989) 1.37
Another negative clinical trial of a new agent for the treatment of sepsis: rethinking the process of developing adjuvant treatments for serious infections. Crit Care Med (1995) 1.37
Raindrop Momentum Triggers Growth of Leaf-Associated Populations of Pseudomonas syringae on Field-Grown Snap Bean Plants. Appl Environ Microbiol (1996) 1.34
Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock. J Clin Invest (1986) 1.34
Endotoxemia causes ileal mucosal acidosis in the absence of mucosal hypoxia in a normodynamic porcine model of septic shock. Crit Care Med (1995) 1.26
Nitric oxide dilates tight junctions and depletes ATP in cultured Caco-2BBe intestinal epithelial monolayers. Am J Physiol (1995) 1.25
Recent implementations of electronic medical records in four family practice residency programs. Acad Med (1997) 1.24
Sedating effects of ethanol and time of drinking. Alcohol Clin Exp Res (1992) 1.22
EUK-8, a synthetic superoxide dismutase and catalase mimetic, ameliorates acute lung injury in endotoxemic swine. J Pharmacol Exp Ther (1995) 1.21
Contribution of the Regulatory Gene lemA to Field Fitness of Pseudomonas syringae pv. syringae. Appl Environ Microbiol (1997) 1.20
Nonoperative treatment of adult splenic trauma: development of a computed tomographic scoring system that detects appropriate candidates for expectant management. J Trauma (1988) 1.18
Effect of mesenteric ischemia and reperfusion or hemorrhagic shock on intestinal mucosal permeability and ATP content in rats. Shock (1999) 1.17
Effects of ethanol, diphenhydramine, and triazolam after a nap. Neuropsychopharmacology (1993) 1.11
A rat resistance exercise regimen attenuates losses of musculoskeletal mass during hindlimb suspension. Acta Physiol Scand (2002) 1.11
Validation of tonometric measurement of gut intramural pH during endotoxemia and mesenteric occlusion in pigs. Am J Physiol (1990) 1.09
Interpreting dual-sugar absorption studies in critically ill patients: what are the implications of apparent increases in intestinal permeability to hydrophilic solutes? Intensive Care Med (1997) 1.09
Norepinephrine alone versus norepinephrine plus low-dose dopamine: enhanced renal blood flow with combination pressor therapy. Crit Care Med (1985) 1.08
Mediastinitis after cardiac surgery--epidemiology and current treatment. Eur J Surg Suppl (1999) 1.08
School readiness. Future Child (1996) 1.02
Cardiovascular performance with E. coli challenges in a canine model of human sepsis. Am J Physiol (1988) 1.02
Protective effects of a novel 32-amino acid C-terminal fragment of CAP18 in endotoxemic pigs. Surgery (1995) 1.02
Ex vivo application of carbon monoxide in University of Wisconsin solution to prevent intestinal cold ischemia/reperfusion injury. Am J Transplant (2006) 0.99
Association of visceral adiposity with oesophageal and junctional adenocarcinomas. Br J Surg (2010) 0.98
Inhibition of prostaglandin synthesis restores normal hemodynamics in canine hyperdynamic sepsis. Ann Surg (1984) 0.98
Acidosis induces hyperpermeability in Caco-2BBe cultured intestinal epithelial monolayers. Am J Physiol (1997) 0.97
The Randomized Nitric Oxide Tocolysis Trial (RNOTT) for the treatment of preterm labor. Am J Obstet Gynecol (2004) 0.95
Cocaine-induced cardiovascular effects: lack of evidence for a central nervous system site of action based on hemodynamic studies with cocaine methiodide. J Cardiovasc Pharmacol (1999) 0.95
Bactericidal/permeability-increasing protein ameliorates acute lung injury in porcine endotoxemia. J Appl Physiol (1985) (1994) 0.95
Differential expression of inducible nitric oxide synthase messenger RNA along the longitudinal and crypt-villus axes of the intestine in endotoxemic rats. Crit Care Med (1998) 0.95
Chemical hypoxia increases junctional permeability and activates electrogenic ion transport in human intestinal epithelial monolayers. Surgery (1994) 0.94
Endotoxin-induced ileal mucosal hyperpermeability in pigs: role of tissue acidosis. Am J Physiol (1994) 0.94
Nitric oxide mediates interferon-gamma-induced hyperpermeability in cultured human intestinal epithelial monolayers. Crit Care Med (1995) 0.94
Pea Ty1-copia group retrotransposons: transpositional activity and use as markers to study genetic diversity in Pisum. Mol Gen Genet (2000) 0.93
Diminished pressor response to exogenous norepinephrine and angiotensin II in septic, unanesthetized rats: evidence for a prostaglandin-mediated effect. J Surg Res (1985) 0.93
Human neutrophil migration is enhanced by beta-endorphin. Life Sci (1984) 0.92
Hyperpermeability and ATP depletion induced by chronic hypoxia or glycolytic inhibition in Caco-2BBe monolayers. Am J Physiol (1996) 0.92
Nitric oxide donor-induced hyperpermeability of cultured intestinal epithelial monolayers: role of superoxide radical, hydroxyl radical, and peroxynitrite. Biochim Biophys Acta (1998) 0.92
Gastric tonometry in healthy volunteers: effect of ranitidine on calculated intramural pH. Crit Care Med (1991) 0.92
Hyperpermeability of intestinal epithelial monolayers is induced by NO: effect of low extracellular pH. Am J Physiol (1997) 0.91
Correction of intramyocardial hypercarbic acidosis with sodium bicarbonate. Circ Shock (1994) 0.91
Determinants of intestinal barrier failure in critical illness. Br J Anaesth (1996) 0.91
Spontaneous regression of metastatic Merkel cell carcinoma. Ir Med J (2010) 0.91
Intestinal epithelial hyperpermeability. Mechanisms and relevance to disease. Gastroenterol Clin North Am (1998) 0.91
Assessment of hepatitis B virus immunization status among North American surgeons. Arch Surg (1994) 0.91
How to keep up with the critical care literature and avoid being buried alive. Crit Care Med (1996) 0.89
Postoperative complications in patients with disabling psychiatric illnesses or intellectual handicaps. A case-controlled, retrospective analysis. Arch Surg (1990) 0.89
Retrograde abdominal visceral perfusion: is it beneficial? Ann Thorac Surg (1995) 0.88
Lisofylline ameliorates intestinal mucosal barrier dysfunction caused by ischemia and ischemia/reperfusion. Shock (1999) 0.88
Intraluminal "balloonless" air tonometry: a new method for determination of gastrointestinal mucosal carbon dioxide tension. Crit Care Med (1994) 0.88
Lisofylline ameliorates intestinal and hepatic injury induced by hemorrhage and resuscitation in rats. Crit Care Med (2000) 0.88
Reduction of myocardial infarction after emergency coronary artery bypass grafting for failed coronary angioplasty with use of a normothermic reperfusion cardioplegia protocol. J Thorac Cardiovasc Surg (1991) 0.88
Liposomal amphotericin B for treatment of pulmonary aspergillosis in a heart transplant patient. J Heart Transplant (1990) 0.88
Renal hemodynamics and prostaglandin E2 excretion in a nonhuman primate model of septic shock. Crit Care Med (1990) 0.86
Prospective randomized study of piperacillin/tazobactam therapy of surgically treated intra-abdominal infection. The Piperacillin/Tazobactam Intra-Abdominal Infection Study Group. Am Surg (1993) 0.86
Polymorphonuclear neutrophil chemiluminescence in whole blood from blunt trauma patients with multiple injuries. J Trauma (1999) 0.85
Does tissue acidosis in sepsis indicate tissue hypoperfusion? Intensive Care Med (1996) 0.85
Mesenteric dysfunction after cardiopulmonary bypass: role of complement C5a. Ann Thorac Surg (2000) 0.85
Plasma levels of 6-keto PGF1 alpha but not TxB2 increase in rats with peritonitis due to cecal ligation. Circ Shock (1985) 0.84
Changes in fetoplacental vessel flow velocity waveforms following maternal administration of betamethasone. Ultrasound Obstet Gynecol (2002) 0.84
lox1:Ps:2, a Pisum sativum seed lipoxygenase gene. Plant Physiol (1994) 0.84
Ileal mucosal oxygen consumption is decreased in endotoxemic rats but is restored toward normal by treatment with aminoguanidine. Crit Care Med (1999) 0.84
The role of serum factors in the acceleration by Freund's complete adjuvant of the growth of transplanted murine leukemic cells. Cancer Res (1975) 0.84
Hypoxic signal transduction in critical illness. Crit Care Med (2000) 0.84
Extracorporeal membrane oxygenation for neonatal respiratory failure. A report of 50 cases. J Thorac Cardiovasc Surg (1989) 0.84
Prostaglandins and sepsis: still a fascinating topic despite almost 40 years of research. Am J Physiol Lung Cell Mol Physiol (2001) 0.83
Application of fiberoptic sensors for the study of hepatic dysoxia in swine hemorrhagic shock. Crit Care Med (2001) 0.83
Delayed treatment with recombinant human tissue factor pathway inhibitor improves survival in rabbits with gram-negative peritonitis. J Infect Dis (1998) 0.83
Leaky gut hypothesis: a historical perspective. Crit Care Med (1990) 0.82
Load-insensitive assessment of myocardial performance after tumor necrosis factor-alpha in dogs. Surgery (1992) 0.82
Role of oxidant stress and iron delocalization in acidosis-induced intestinal epithelial hyperpermeability. Shock (1997) 0.82
DNA probes and the detection of food-borne pathogens using the polymerase chain reaction. Biochem Soc Trans (1991) 0.82
Acquired interferon gamma responsiveness during Caco-2 cell differentiation: effects on iNOS gene expression. Gut (1999) 0.82
Antibody stimulation of tumour growth in T-cell depleted mice. Nature (1975) 0.81
Microcirculatory weak units--an alternative explanation. Crit Care Med (2000) 0.81